StockData
Rallybio Corp logo

Rallybio Corp (RLYB) stock

RLYBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/30
$15.26−0.03 (-0.20%)

Close on Nov 18, 2026Market cap $82.16MP/E 3.3Yield –

Rallybio enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Rallybio's enterprise value was -$8.95M on Nov 11, 2026, against -$32.00M a year earlier. Over the last 5 years it ranged from -$70.37M to $317.54M, with a median of -$8.95M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$8.95M–
2025Dec 31, 2025-$30.53M–
2024Dec 31, 2024-$35.27M–
2023Dec 29, 2023-$31.06M-139.6%
2022Dec 30, 2022$78.44M-34.4%
2021Dec 31, 2021$119.54M–

More Rallybio figures

See a number that looks wrong?